Kyongbo Pharmaceutical Co., Ltd (214390.KS) KSC

5,800.00

+10(+0.17%)

Updated at January 15 11:49AM

Currency In KRW

Valuation

Market Cap148.7B
Enterprise Value236.01B
P/E Ratio59.11
PEG Ratio0.12
Price/Sales Ratio0.55
Price/Book Ratio0.96
Enterprise/Revenue1.03
Enterprise/EBITDA14.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue238.56B
Revenue/Share10,564.28
Gross Profit82.42B
EBITDA21.6B
Net Income4.64B
Diluted EPS194.06

Balance Sheet

Total Cash4.41B
Total Cash/Share184.66
Total Debt123.89B
Total Debt/Equity0.85
Current Ratio0.95
Book Value Per Share6,085.5

Price History

52-Week Change-17.3
52-Week High7,160
52-Week Low4,755
Moving Average 50 Days5,981.4
Moving Average 200 Days5,527.33

Statistics

Average Volume38,727
Shares Outstanding23.91M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.51
Last Split FactorN/A
Last Split DateN/A